Novartis delivers double-digit sales growth and core margin expansion in Q1; FY 2024 guidance raised
GlobeNewswire
*Ad hoc announcement pursuant to Art. 53 LR*
· *Q1 net sales grew +11% (cc*^*1**, +10% USD) with core operating income..
*Ad hoc announcement pursuant to Art. 53 LR*
· *Q1 net sales grew +11% (cc*^*1**, +10% USD) with core operating income..
- FY24: Expects $118.5M revenue, $14.4M Adjusted EBITDA* (excluding $3.5M CPS division loss)
- Q4 FY24: Expects $30.3M..
Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The "Saudi Arabia Perfume Market Report by Type, Value, Gender, and Company Analysis..